Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCAT 2023 | Defining global strategies to improve outcomes in SCD

Mariane De Montalembert • 27 Oct 2023
ASCAT 2023
Non-Malignant Sickle Cell Disease

Mariane De Montalembert, MD, PhD, Necker Hospital APHP, Paris, France, discusses strategies to optimize sickle cell disease (SCD) outcomes in various patient populations, and emphasizes the importance of improving organization of healthcare systems and providing education to healthcare professionals and patients. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Mariane De Montalembert

0:57
Age-related complications in SCD
Mariane De Montalembert • 27 Oct 2023
0:50
ERN-EuroBloodNet and SCD management in Europe
Mariane De Montalembert • 27 Oct 2023
2:23
The challenges of transitioning from pediatric to adult care in SCD
Mariane De Montalembert • 27 Oct 2023

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals